AXIONOVA provides two-path access to Research Use Only compound records, AXIS device workflows, CDM cartridge identity, SENSE physiological monitoring, HALO biometric intelligence, and AXIONOVA bio review tools. Licensed practitioners and qualified organizations use Path 1. Trainers, spas, coaches, and individuals use Path 2 and are routed through AXIONOVA's on-staff doctors for telehealth oversight.
The model is access with oversight. It is not unmanaged access, unsupervised self-administration, therapeutic sale, emergency-service activation, or consumer resale.
AXIONOVA governed access serves both paths: licensed practitioners, clinics, organizations, and review teams on Path 1, and trainers, spas, coaches, and individuals routed through on-staff doctors on Path 2. Each path provides structured Research Use Only protocol context. Access may include compound records, AXIS event context, CDM cartridge identity, SENSE wellness trends, HALO biometric intelligence, labs when provided, symptoms, nutrition, and practitioner notes inside AXIONOVA bio.
SENSE data should be treated as wellness intelligence unless and until a module is validated for a regulated use. Ring data supports PPG, SpO2 research trend support, sleep context, temperature, motion, and recovery trends.
Bracelet data may add EDA, MAX30009 BioZ, optional AS7058 ECG pathway if implemented, thermal trend, motion, and secure BLE context. No access workflow should present SENSE as a diagnostic replacement, glucose monitor, lab replacement, or automated dosing system.
AXIONOVA accepts applications from licensed practitioners, clinics, medical institutes, research entities, trainers, spas, coaches, and individuals. Qualification depends on the appropriate oversight path, intended research context, consent readiness, privacy requirements, jurisdictional availability, documentation requirements, and chain-of-custody controls. Applicants who do not bring their own licensed practitioner are routed to AXIONOVA's on-staff doctors for telehealth oversight.
The most-asked questions from licensed practitioners, organizations, research entities, trainers, spas, coaches, and individuals applying for AXIONOVA access through either path.
AXIONOVA requires professional credentials, license or NPI information where applicable, institutional affiliation, entity details, and intended research context. Research entities may be asked for oversight documentation or IRB-related materials depending on use case.
Most complete applications are reviewed within 24 to 48 hours. Institutional reviews, incomplete files, or documentation-dependent applications may take longer.
AXIONOVA does not provide unmanaged access, unsupervised self-administration, resale channels, or therapeutic-use claims. Individuals may apply through Path 2 and, where eligible, are routed through AXIONOVA's on-staff doctors for telehealth oversight. Licensed practitioners and qualified organizations may apply through Path 1.
Yes. AXIONOVA provides ALETHRA-governed documentation for identity, lot records, certificate materials, release records, and chain-of-custody events where applicable.
AXIS is available through governed partner workflows. The device uses disposable CDM cartridges, NFC cartridge identity, BLE 5.3 event records, manual dose selection, electronic verification, and ALETHRA authorization controls.
Yes. ALETHA AI coaching, protocol personalization, diet programming, guided education, and 24/7 support are active and operational. ALETHRA governance is also active and remains the platform layer for identity, authorization, compliance, and event records.